Cardiac Rhythm Management

The Resonate^TM family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems feature the HeartLogic^TM Heart Failure Diagnostic. The Resonate devices, which are approved by the U.S. Food and Drug Administration for conditional use in a magnetic resonance imaging (MRI) environment, also incorporate SmartCRT™ Technology, which helps physicians determine where, when and how to pace, while industry-leading device longevity is provided through EnduraLife™ Battery Technology.

The EMBLEM™ MRI S-ICD System is the only subcutaneous implantable defibrillator that provides protection for patients at risk for sudden cardiac death while remaining entirely outside the rib cage and just beneath the skin of a patient.

The LUX-Dx™ Insertable Cardiac Monitor (ICM) System is a long-term diagnostic device inserted under the skin of patients to detect arrhythmias associated with conditions such as atrial fibrillation, cryptogenic stroke and syncope. Designed with a dual-stage algorithm that detects and then verifies potential arrhythmias before an alert is sent to clinicians, it has an intuitive implant procedure and allows for remote programming. 

Boston Scientific Cardiac Diagnostics, a wholly owned subsidiary of Boston Scientific, provides the BodyGuardian™ MINI which is a small, reusable, four-in-one cardiac monitoring device that includes mobile cardiac telemetry, cardiac event monitoring, and short- and long-term holter monitoring services. Unlike many monitors, the BodyGuardian MINI has multiple placement options and offers a wearable patch that can be moved and reapplied to optimize comfort and wearability. During the monitoring period it can be replaced without jeopardizing data collection or requiring patients to return to the clinic, and its waterproof design allows patients the freedom to go about their daily routine without interrupting cardiac monitoring.